PROSTAGLANDINS

[1] AIKEN JW, 1974, PHARMACOLOGIST, V16, P295

[2] AIKEN JW, 1983, ADV PROSTAG THROMB L, V11, P253

[3] AIKEN JW, 1981, J PHARMACOL EXP THER, V219, P299

[4] AIKEN JW, 1973, J PHARMACOL EXP THER, V184, P678

[5] AIKEN JW, 1974, POL J PHARMACOL PHAR, V26, P217

[6] AIKEN JW, 1976, FED PROC, V35, P803

[7] PREVENTION OF BLOCKAGE OF PARTIALLY OBSTRUCTED CORONARY-ARTERIES WITH PROSTACYCLIN CORRELATES WITH INHIBITION OF PLATELET-AGGREGATION [J]. PROSTAGLANDINS, 1979, 17 (04): : 483 - 494

[8] AIKEN JW, 1978, 7TH INT C PHARM PAR, P805

[9] EVIDENCE FOR SEPARATE PGD2 AND PGF2-ALPHA RECEPTORS IN THE CANINE MESENTERIC VASCULAR BED [J]. PROSTAGLANDINS, 1979, 18 (02): : 221 - 233

[10] PLATELET-AGGREGATION IN PARTIALLY OBSTRUCTED VESSELS AND ITS ELIMINATION WITH ASPIRIN [J]. CIRCULATION, 1976, 54 (03) : 365 - 370

[1] AIKEN JW, 1974, PHARMACOLOGIST, V16, P295

[2] AIKEN JW, 1983, ADV PROSTAG THROMB L, V11, P253

[3] AIKEN JW, 1981, J PHARMACOL EXP THER, V219, P299

[4] AIKEN JW, 1973, J PHARMACOL EXP THER, V184, P678

[5] AIKEN JW, 1974, POL J PHARMACOL PHAR, V26, P217

[6] AIKEN JW, 1976, FED PROC, V35, P803

[7] PREVENTION OF BLOCKAGE OF PARTIALLY OBSTRUCTED CORONARY-ARTERIES WITH PROSTACYCLIN CORRELATES WITH INHIBITION OF PLATELET-AGGREGATION [J]. PROSTAGLANDINS, 1979, 17 (04): : 483 - 494

[8] AIKEN JW, 1978, 7TH INT C PHARM PAR, P805

[9] EVIDENCE FOR SEPARATE PGD2 AND PGF2-ALPHA RECEPTORS IN THE CANINE MESENTERIC VASCULAR BED [J]. PROSTAGLANDINS, 1979, 18 (02): : 221 - 233

[10] PLATELET-AGGREGATION IN PARTIALLY OBSTRUCTED VESSELS AND ITS ELIMINATION WITH ASPIRIN [J]. CIRCULATION, 1976, 54 (03) : 365 - 370